

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.49296368 |
| 2 | protein localization to endosome (GO:0036010) | 4.24615364 |
| 3 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.04819426 |
| 4 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.91499802 |
| 5 | apoptotic process involved in morphogenesis (GO:0060561) | 3.77680496 |
| 6 | barbed-end actin filament capping (GO:0051016) | 3.70850230 |
| 7 | regulation of early endosome to late endosome transport (GO:2000641) | 3.60829614 |
| 8 | pentose-phosphate shunt (GO:0006098) | 3.52589004 |
| 9 | mannose metabolic process (GO:0006013) | 3.50489604 |
| 10 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.47330949 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 3.42145621 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 3.42145621 |
| 13 | pinocytosis (GO:0006907) | 3.33387956 |
| 14 | amyloid precursor protein catabolic process (GO:0042987) | 3.32266118 |
| 15 | adherens junction assembly (GO:0034333) | 3.29739142 |
| 16 | negative regulation of cell size (GO:0045792) | 3.27420076 |
| 17 | cell-substrate adherens junction assembly (GO:0007045) | 3.21652440 |
| 18 | focal adhesion assembly (GO:0048041) | 3.21652440 |
| 19 | proline biosynthetic process (GO:0006561) | 3.21397060 |
| 20 | glucose catabolic process (GO:0006007) | 3.17269589 |
| 21 | stress fiber assembly (GO:0043149) | 3.17198515 |
| 22 | modulation by symbiont of host cellular process (GO:0044068) | 3.07480537 |
| 23 | activation of Rac GTPase activity (GO:0032863) | 3.06574743 |
| 24 | cell-substrate junction assembly (GO:0007044) | 3.05890543 |
| 25 | modulation by virus of host process (GO:0019054) | 3.02203142 |
| 26 | protein retention in ER lumen (GO:0006621) | 2.99168459 |
| 27 | NADPH regeneration (GO:0006740) | 2.96258312 |
| 28 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.94850674 |
| 29 | maternal placenta development (GO:0001893) | 2.93424206 |
| 30 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92915706 |
| 31 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.90547179 |
| 32 | response to laminar fluid shear stress (GO:0034616) | 2.87156928 |
| 33 | tooth mineralization (GO:0034505) | 2.84783534 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84291679 |
| 35 | negative regulation of necroptotic process (GO:0060546) | 2.83018840 |
| 36 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.82414635 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.78996029 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.78996029 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 2.78996029 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 2.78996029 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 2.78996029 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.78996029 |
| 43 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.78412745 |
| 44 | GDP-mannose metabolic process (GO:0019673) | 2.74245398 |
| 45 | embryonic process involved in female pregnancy (GO:0060136) | 2.73162112 |
| 46 | positive regulation of receptor recycling (GO:0001921) | 2.72798054 |
| 47 | negative regulation of viral release from host cell (GO:1902187) | 2.70825753 |
| 48 | response to peptidoglycan (GO:0032494) | 2.70365777 |
| 49 | lymph vessel development (GO:0001945) | 2.69298214 |
| 50 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.67318325 |
| 51 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.66552739 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65302629 |
| 53 | amyloid precursor protein metabolic process (GO:0042982) | 2.65157014 |
| 54 | epithelial cell-cell adhesion (GO:0090136) | 2.64882159 |
| 55 | regulation of chromatin binding (GO:0035561) | 2.63896583 |
| 56 | modulation by virus of host morphology or physiology (GO:0019048) | 2.59679111 |
| 57 | negative regulation of cell killing (GO:0031342) | 2.57902846 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57902846 |
| 59 | regulation of extracellular matrix disassembly (GO:0010715) | 2.57780019 |
| 60 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.56175111 |
| 61 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.55638098 |
| 62 | hemidesmosome assembly (GO:0031581) | 2.54988686 |
| 63 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53676440 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53101670 |
| 65 | positive regulation of histone deacetylation (GO:0031065) | 2.52860166 |
| 66 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.52322982 |
| 67 | basement membrane organization (GO:0071711) | 2.51174389 |
| 68 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.50776895 |
| 69 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.49468776 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.48204315 |
| 71 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.48130758 |
| 72 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.47960122 |
| 73 | positive regulation of myotube differentiation (GO:0010831) | 2.47871377 |
| 74 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.46549436 |
| 75 | pentose metabolic process (GO:0019321) | 2.46165099 |
| 76 | glucose 6-phosphate metabolic process (GO:0051156) | 2.46076564 |
| 77 | regulation of necroptotic process (GO:0060544) | 2.45218692 |
| 78 | desmosome organization (GO:0002934) | 2.44030434 |
| 79 | negative regulation of fatty acid transport (GO:2000192) | 2.43897926 |
| 80 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40698737 |
| 81 | cellular response to virus (GO:0098586) | 2.38867936 |
| 82 | negative regulation of myotube differentiation (GO:0010832) | 2.37926159 |
| 83 | regulation of necrotic cell death (GO:0010939) | 2.36372276 |
| 84 | regulation of leukocyte degranulation (GO:0043300) | 2.35251475 |
| 85 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34457879 |
| 86 | apoptotic process involved in development (GO:1902742) | 2.33895914 |
| 87 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.33202919 |
| 88 | cellular protein complex localization (GO:0034629) | 2.33039273 |
| 89 | regulation of defense response to virus by virus (GO:0050690) | 2.32206694 |
| 90 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.30608278 |
| 91 | membrane protein ectodomain proteolysis (GO:0006509) | 2.29207691 |
| 92 | mammary gland epithelial cell differentiation (GO:0060644) | 2.29038906 |
| 93 | protein maturation by protein folding (GO:0022417) | 2.27810707 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.26589491 |
| 95 | semaphorin-plexin signaling pathway (GO:0071526) | 2.24826275 |
| 96 | skin morphogenesis (GO:0043589) | 2.23475715 |
| 97 | signal complex assembly (GO:0007172) | 2.20617841 |
| 98 | hyaluronan catabolic process (GO:0030214) | 2.20597174 |
| 99 | UV protection (GO:0009650) | 2.19732571 |
| 100 | detection of other organism (GO:0098543) | 2.18920830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20860255 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.94617656 |
| 3 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.72653937 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.63399252 |
| 5 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.61749753 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45589277 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.30446179 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29776095 |
| 9 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.27317644 |
| 10 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.27126479 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26799125 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24429043 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21391530 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15625126 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08941722 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96676125 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93854902 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93830142 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.90737868 |
| 20 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.65022942 |
| 21 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.64246301 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63040107 |
| 23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60852622 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59657805 |
| 25 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.55925877 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54354089 |
| 27 | * P68_20966046_ChIP-Seq_HELA_Human | 1.54004241 |
| 28 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53410450 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53365263 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.51989511 |
| 31 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.51952198 |
| 32 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51220829 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48697649 |
| 34 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47979874 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44774086 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44040579 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.43809961 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.43082291 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41921050 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40195396 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38742347 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38434780 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37020693 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36567586 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36135361 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35603827 |
| 47 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34228674 |
| 48 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32720246 |
| 49 | * MAF_26560356_Chip-Seq_TH2_Human | 1.30651172 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30238644 |
| 51 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.30216408 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29901256 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29125374 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27889273 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27079116 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23687887 |
| 57 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.23013989 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22094874 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21611726 |
| 60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20393421 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19807459 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19172384 |
| 63 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19007605 |
| 64 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18627238 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17218219 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17152782 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16664395 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15903296 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15869433 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14916573 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13366198 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12997911 |
| 73 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12312869 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11385387 |
| 75 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.10827764 |
| 76 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.10623607 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08353656 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07682460 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07282572 |
| 80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07202535 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06672648 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06307968 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04243893 |
| 84 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03359652 |
| 85 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.03180969 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02262811 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01355504 |
| 88 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00882468 |
| 89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99853100 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99670128 |
| 91 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.99007396 |
| 92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98727666 |
| 93 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98233721 |
| 94 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.98224016 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96140239 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95942099 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95927742 |
| 98 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95883953 |
| 99 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94621535 |
| 100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94459802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.79827288 |
| 2 | MP0005451_abnormal_body_composition | 3.14027013 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.60661913 |
| 4 | MP0008260_abnormal_autophagy | 2.59847111 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.56243973 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.56156989 |
| 7 | MP0001849_ear_inflammation | 2.51107511 |
| 8 | MP0004858_abnormal_nervous_system | 2.38339061 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.34177579 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.27788070 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.24622679 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.20143444 |
| 13 | MP0003303_peritoneal_inflammation | 2.15118081 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.12748269 |
| 15 | MP0002796_impaired_skin_barrier | 2.07168836 |
| 16 | MP0003436_decreased_susceptibility_to | 2.05217912 |
| 17 | MP0003453_abnormal_keratinocyte_physiol | 2.03172966 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.02934630 |
| 19 | MP0009840_abnormal_foam_cell | 1.88982707 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.77934842 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.77145490 |
| 22 | MP0005623_abnormal_meninges_morphology | 1.69874200 |
| 23 | MP0005501_abnormal_skin_physiology | 1.66168804 |
| 24 | MP0009278_abnormal_bone_marrow | 1.65968720 |
| 25 | MP0004233_abnormal_muscle_weight | 1.63613796 |
| 26 | MP0002249_abnormal_larynx_morphology | 1.63562458 |
| 27 | MP0000858_altered_metastatic_potential | 1.60987342 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.60957408 |
| 29 | MP0004947_skin_inflammation | 1.55067017 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.46966549 |
| 31 | MP0003091_abnormal_cell_migration | 1.38286568 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.37913363 |
| 33 | MP0003279_aneurysm | 1.35966230 |
| 34 | MP0000490_abnormal_crypts_of | 1.35262538 |
| 35 | MP0005409_darkened_coat_color | 1.32888702 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.31761651 |
| 37 | MP0002060_abnormal_skin_morphology | 1.26201699 |
| 38 | MP0000733_abnormal_muscle_development | 1.25589655 |
| 39 | MP0005023_abnormal_wound_healing | 1.23518526 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.22713477 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.19590625 |
| 42 | MP0004510_myositis | 1.16439140 |
| 43 | MP0004272_abnormal_basement_membrane | 1.16329926 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.15603742 |
| 45 | MP0000537_abnormal_urethra_morphology | 1.14818473 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.14317774 |
| 47 | MP0001958_emphysema | 1.13803996 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.12137965 |
| 49 | MP0005670_abnormal_white_adipose | 1.07530678 |
| 50 | MP0003075_altered_response_to | 1.06685900 |
| 51 | MP0009053_abnormal_anal_canal | 1.03157947 |
| 52 | MP0002419_abnormal_innate_immunity | 1.02808951 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.01845082 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.00675429 |
| 55 | MP0003329_amyloid_beta_deposits | 0.99854240 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.97650590 |
| 57 | MP0005025_abnormal_response_to | 0.96792951 |
| 58 | MP0001216_abnormal_epidermal_layer | 0.95575186 |
| 59 | MP0001873_stomach_inflammation | 0.94290832 |
| 60 | MP0001730_embryonic_growth_arrest | 0.93327091 |
| 61 | MP0009931_abnormal_skin_appearance | 0.92961205 |
| 62 | MP0000751_myopathy | 0.92854905 |
| 63 | MP0010155_abnormal_intestine_physiology | 0.91188937 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 0.91025588 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.90613542 |
| 66 | MP0004381_abnormal_hair_follicle | 0.89733044 |
| 67 | MP0000759_abnormal_skeletal_muscle | 0.89335044 |
| 68 | MP0003448_altered_tumor_morphology | 0.88786922 |
| 69 | MP0000467_abnormal_esophagus_morphology | 0.88422554 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 0.88285143 |
| 71 | MP0005621_abnormal_cell_physiology | 0.86473211 |
| 72 | MP0000750_abnormal_muscle_regeneration | 0.86118369 |
| 73 | MP0000747_muscle_weakness | 0.85995870 |
| 74 | MP0003828_pulmonary_edema | 0.85259953 |
| 75 | MP0000681_abnormal_thyroid_gland | 0.84433237 |
| 76 | MP0000685_abnormal_immune_system | 0.83077635 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.79601713 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.79323300 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 0.79183190 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.79049547 |
| 81 | MP0005083_abnormal_biliary_tract | 0.78919974 |
| 82 | MP0000343_altered_response_to | 0.78799910 |
| 83 | MP0005000_abnormal_immune_tolerance | 0.78473285 |
| 84 | MP0001346_abnormal_lacrimal_gland | 0.77230883 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.74818678 |
| 86 | MP0001835_abnormal_antigen_presentation | 0.74746995 |
| 87 | MP0001661_extended_life_span | 0.74674315 |
| 88 | MP0005390_skeleton_phenotype | 0.74032270 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.73542900 |
| 90 | MP0002398_abnormal_bone_marrow | 0.73150304 |
| 91 | MP0005275_abnormal_skin_tensile | 0.72530766 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.72468475 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.72468475 |
| 94 | MP0001819_abnormal_immune_cell | 0.70746385 |
| 95 | MP0003724_increased_susceptibility_to | 0.70709991 |
| 96 | MP0002420_abnormal_adaptive_immunity | 0.70455524 |
| 97 | MP0005387_immune_system_phenotype | 0.69799724 |
| 98 | MP0001790_abnormal_immune_system | 0.69799724 |
| 99 | MP0006082_CNS_inflammation | 0.68881427 |
| 100 | MP0002132_abnormal_respiratory_system | 0.68299368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.15839225 |
| 2 | Premature rupture of membranes (HP:0001788) | 3.13965600 |
| 3 | Hyperacusis (HP:0010780) | 3.03418470 |
| 4 | Vertebral compression fractures (HP:0002953) | 2.97040631 |
| 5 | Increased connective tissue (HP:0009025) | 2.86553437 |
| 6 | Distal lower limb amyotrophy (HP:0008944) | 2.75590150 |
| 7 | Achilles tendon contracture (HP:0001771) | 2.71562116 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 2.68608363 |
| 9 | Fragile skin (HP:0001030) | 2.58228982 |
| 10 | Ulnar bowing (HP:0003031) | 2.50483927 |
| 11 | Eczematoid dermatitis (HP:0000976) | 2.46792078 |
| 12 | Broad face (HP:0000283) | 2.41637758 |
| 13 | Distal upper limb amyotrophy (HP:0007149) | 2.41014043 |
| 14 | Upper limb amyotrophy (HP:0009129) | 2.41014043 |
| 15 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.39189558 |
| 16 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.38502738 |
| 17 | Thin bony cortex (HP:0002753) | 2.38422360 |
| 18 | Abnormality of the Achilles tendon (HP:0005109) | 2.37163672 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.34750097 |
| 20 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32678983 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.31297653 |
| 22 | Stridor (HP:0010307) | 2.30114413 |
| 23 | Recurrent abscess formation (HP:0002722) | 2.29364745 |
| 24 | Short nail (HP:0001799) | 2.21372745 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21221164 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.20539046 |
| 27 | Myopathic facies (HP:0002058) | 2.18877228 |
| 28 | Cellulitis (HP:0100658) | 2.15453932 |
| 29 | Genu recurvatum (HP:0002816) | 2.08373679 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.07420785 |
| 31 | Spinal rigidity (HP:0003306) | 2.05895632 |
| 32 | Polygenic inheritance (HP:0010982) | 2.05477229 |
| 33 | Long palpebral fissure (HP:0000637) | 2.04916954 |
| 34 | Cervical subluxation (HP:0003308) | 2.04808968 |
| 35 | Disproportionate tall stature (HP:0001519) | 2.03349088 |
| 36 | Bulbar palsy (HP:0001283) | 1.99374472 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98474046 |
| 38 | Difficulty climbing stairs (HP:0003551) | 1.98098250 |
| 39 | Blue sclerae (HP:0000592) | 1.96557602 |
| 40 | Abnormality of macrophages (HP:0004311) | 1.94106816 |
| 41 | Mitral regurgitation (HP:0001653) | 1.93535136 |
| 42 | Elbow flexion contracture (HP:0002987) | 1.93223322 |
| 43 | Flat acetabular roof (HP:0003180) | 1.91691810 |
| 44 | Dilatation of the ascending aorta (HP:0005111) | 1.89134612 |
| 45 | Broad distal phalanx of finger (HP:0009836) | 1.88644614 |
| 46 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88105260 |
| 47 | Osteolytic defects of the hand bones (HP:0009699) | 1.88105260 |
| 48 | Upper motor neuron abnormality (HP:0002127) | 1.88054515 |
| 49 | Generalized amyotrophy (HP:0003700) | 1.87864862 |
| 50 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86938561 |
| 51 | Shallow orbits (HP:0000586) | 1.85595290 |
| 52 | Atrophic scars (HP:0001075) | 1.84392662 |
| 53 | Insomnia (HP:0100785) | 1.83906957 |
| 54 | Axonal loss (HP:0003447) | 1.82397386 |
| 55 | Abnormality of the thoracic spine (HP:0100711) | 1.81751836 |
| 56 | Ankyloglossia (HP:0010296) | 1.79948709 |
| 57 | Dysostosis multiplex (HP:0000943) | 1.78534822 |
| 58 | Trismus (HP:0000211) | 1.78208655 |
| 59 | Abnormality of oral frenula (HP:0000190) | 1.76866341 |
| 60 | Hemorrhage of the eye (HP:0011885) | 1.76561408 |
| 61 | Spinal cord compression (HP:0002176) | 1.76496351 |
| 62 | Lower limb amyotrophy (HP:0007210) | 1.76253426 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 1.73502042 |
| 64 | Hypertensive crisis (HP:0100735) | 1.72839920 |
| 65 | Hyperparathyroidism (HP:0000843) | 1.72832476 |
| 66 | Hand muscle atrophy (HP:0009130) | 1.71695023 |
| 67 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.71660234 |
| 68 | Biconcave vertebral bodies (HP:0004586) | 1.68804664 |
| 69 | Abnormality of the umbilical cord (HP:0010881) | 1.68232021 |
| 70 | Loss of speech (HP:0002371) | 1.67627076 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 1.66966827 |
| 72 | Bone pain (HP:0002653) | 1.66363918 |
| 73 | Subacute progressive viral hepatitis (HP:0006572) | 1.66127867 |
| 74 | Ankle contracture (HP:0006466) | 1.66009308 |
| 75 | Selective tooth agenesis (HP:0001592) | 1.65341212 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 1.65074357 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.64908174 |
| 78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.64908174 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 1.64908174 |
| 80 | Gingivitis (HP:0000230) | 1.64858188 |
| 81 | Truncus arteriosus (HP:0001660) | 1.64782262 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64461588 |
| 83 | Obstructive lung disease (HP:0006536) | 1.64461588 |
| 84 | Progressive muscle weakness (HP:0003323) | 1.64175327 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 1.63416290 |
| 86 | Abnormal ossification of hand bones (HP:0005921) | 1.63210184 |
| 87 | Hypertriglyceridemia (HP:0002155) | 1.63173212 |
| 88 | Asymmetry of the thorax (HP:0001555) | 1.62192036 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 1.60269106 |
| 90 | Increased IgE level (HP:0003212) | 1.59959266 |
| 91 | Gastrointestinal dysmotility (HP:0002579) | 1.59840537 |
| 92 | Colitis (HP:0002583) | 1.59570800 |
| 93 | Hypercortisolism (HP:0001578) | 1.58788377 |
| 94 | Polycythemia (HP:0001901) | 1.57634737 |
| 95 | Petechiae (HP:0000967) | 1.56635681 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.56161657 |
| 97 | Wormian bones (HP:0002645) | 1.55626173 |
| 98 | Reticulocytosis (HP:0001923) | 1.55580484 |
| 99 | Rectal prolapse (HP:0002035) | 1.55252648 |
| 100 | Advanced eruption of teeth (HP:0006288) | 1.55191731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.76048856 |
| 2 | SMG1 | 4.26622964 |
| 3 | PRPF4B | 3.53878679 |
| 4 | ERN1 | 3.26632903 |
| 5 | IRAK3 | 3.20457002 |
| 6 | SIK1 | 2.60487215 |
| 7 | NME2 | 2.39838737 |
| 8 | ICK | 2.29772932 |
| 9 | MAP2K3 | 2.25289645 |
| 10 | EEF2K | 2.23398312 |
| 11 | TTN | 1.94290240 |
| 12 | EPHA2 | 1.87671797 |
| 13 | TAOK2 | 1.87075007 |
| 14 | MAP3K10 | 1.79812733 |
| 15 | RIPK1 | 1.72366701 |
| 16 | ARAF | 1.64053564 |
| 17 | MAP3K11 | 1.60276488 |
| 18 | PKN2 | 1.57051211 |
| 19 | MAP3K3 | 1.53353344 |
| 20 | MST1R | 1.43078232 |
| 21 | PAK4 | 1.41457506 |
| 22 | TAOK1 | 1.32914387 |
| 23 | PRKD3 | 1.32851070 |
| 24 | TESK1 | 1.30993218 |
| 25 | IRAK4 | 1.24775591 |
| 26 | MAP3K13 | 1.23062818 |
| 27 | CDK12 | 1.19647725 |
| 28 | MAP3K1 | 1.14341175 |
| 29 | PTK6 | 1.14265226 |
| 30 | IRAK2 | 1.11945602 |
| 31 | MAP4K1 | 1.08715355 |
| 32 | BMX | 1.08558024 |
| 33 | PDGFRA | 1.08169499 |
| 34 | PRKD2 | 1.07379862 |
| 35 | TESK2 | 1.07007926 |
| 36 | FGFR4 | 1.05931141 |
| 37 | KSR2 | 1.05421103 |
| 38 | BRAF | 1.00489020 |
| 39 | RIPK4 | 0.95121648 |
| 40 | TYK2 | 0.94798649 |
| 41 | EPHB1 | 0.93437089 |
| 42 | LMTK2 | 0.93210380 |
| 43 | PDPK1 | 0.92721488 |
| 44 | MAP3K8 | 0.89718888 |
| 45 | GRK6 | 0.89693447 |
| 46 | RPS6KA2 | 0.89376578 |
| 47 | PTK2 | 0.88852328 |
| 48 | ZAP70 | 0.87861798 |
| 49 | PIM2 | 0.87480824 |
| 50 | TBK1 | 0.83160713 |
| 51 | RPS6KL1 | 0.80932350 |
| 52 | RPS6KC1 | 0.80932350 |
| 53 | MARK2 | 0.80807303 |
| 54 | MTOR | 0.79855044 |
| 55 | MAPK11 | 0.79516433 |
| 56 | PRKG2 | 0.79008637 |
| 57 | CDC42BPA | 0.75508612 |
| 58 | CSK | 0.72171469 |
| 59 | LRRK2 | 0.70546011 |
| 60 | ILK | 0.64371493 |
| 61 | MAP3K6 | 0.63257441 |
| 62 | LATS2 | 0.60901036 |
| 63 | MAP2K2 | 0.60753582 |
| 64 | VRK2 | 0.60359926 |
| 65 | MOS | 0.59413574 |
| 66 | CDK4 | 0.57425708 |
| 67 | HIPK2 | 0.57306542 |
| 68 | KDR | 0.56898113 |
| 69 | RPS6KA6 | 0.54899827 |
| 70 | RPS6KB2 | 0.54884749 |
| 71 | MAPK12 | 0.54338932 |
| 72 | CDK7 | 0.54196836 |
| 73 | STK38 | 0.53490017 |
| 74 | JAK3 | 0.53317062 |
| 75 | ABL2 | 0.51770735 |
| 76 | SCYL2 | 0.50609875 |
| 77 | PDK1 | 0.49955382 |
| 78 | MET | 0.48121801 |
| 79 | FES | 0.45221666 |
| 80 | BLK | 0.44364792 |
| 81 | STK10 | 0.42599241 |
| 82 | AURKA | 0.41911369 |
| 83 | EPHB2 | 0.40972767 |
| 84 | MAP3K14 | 0.40782609 |
| 85 | DDR2 | 0.40004724 |
| 86 | MELK | 0.39800047 |
| 87 | TNK2 | 0.39266032 |
| 88 | CAMKK1 | 0.39112917 |
| 89 | STK4 | 0.37573110 |
| 90 | NTRK1 | 0.37034792 |
| 91 | CAMK1D | 0.36306809 |
| 92 | MAPKAPK2 | 0.35307258 |
| 93 | HCK | 0.35224339 |
| 94 | TAF1 | 0.35171713 |
| 95 | TGFBR2 | 0.34656407 |
| 96 | AKT2 | 0.33745792 |
| 97 | RET | 0.32812334 |
| 98 | PAK1 | 0.31949838 |
| 99 | DAPK3 | 0.31907513 |
| 100 | DAPK1 | 0.31882444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.38556182 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37887515 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 2.35337042 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.19974909 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.14321904 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.07814544 |
| 7 | Bladder cancer_Homo sapiens_hsa05219 | 1.96553512 |
| 8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.92106101 |
| 9 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.89760320 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.78198971 |
| 11 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.74590253 |
| 12 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.74160701 |
| 13 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.71941213 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53974672 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48781058 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48227415 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45278330 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44974785 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.44135366 |
| 20 | Endometrial cancer_Homo sapiens_hsa05213 | 1.42971561 |
| 21 | Thyroid cancer_Homo sapiens_hsa05216 | 1.40440669 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37513142 |
| 23 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27466208 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24492398 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.23601699 |
| 26 | Glioma_Homo sapiens_hsa05214 | 1.19650321 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16759414 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16672601 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.16667811 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15742559 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.14831479 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14564966 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.14420880 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.11454411 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11176152 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10743942 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10223982 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07561145 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06371354 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04717548 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.03720544 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03471991 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.02542118 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.01604105 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98634182 |
| 46 | Endocytosis_Homo sapiens_hsa04144 | 0.97582427 |
| 47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.95205125 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94312968 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94154097 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93257915 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.92819407 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92557927 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90403205 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89762574 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89586245 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89187422 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89077336 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88770401 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.87020957 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86665207 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.84513005 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81719143 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80940444 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80019978 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78055383 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77931856 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77333918 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76841764 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.75949101 |
| 70 | Prostate cancer_Homo sapiens_hsa05215 | 0.75477673 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75247168 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.72852141 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72611974 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72543442 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70899753 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70313953 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69915980 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69812255 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68325540 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67738027 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.67617725 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65768124 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65694116 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64757054 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64666442 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64653404 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63378431 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63161060 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.60816741 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.60674332 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59184981 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56262880 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55217190 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54684118 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54147916 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.53731864 |
| 97 | Base excision repair_Homo sapiens_hsa03410 | 0.52188825 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.50335930 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49676124 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48871099 |

